3TP.F - Acerus Pharmaceuticals Corporation

Frankfurt - Frankfurt Delayed Price. Currency in EUR
-0.0065 (-16.25%)
As of 8:00AM CEST. Market open.
Stock chart is not supported by your current browser
Previous Close0.0400
Bid0.0470 x 1692400
Ask0.0835 x 1500000
Day's Range0.0335 - 0.0335
52 Week Range0.0335 - 0.1460
Avg. Volume0
Market Cap8.751M
Beta (3Y Monthly)0.37
PE Ratio (TTM)N/A
EPS (TTM)-0.0640
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Imagine Owning Acerus Pharmaceuticals (TSE:ASP) And Trying To Stomach The 73% Share Price Drop
    Simply Wall St.

    Imagine Owning Acerus Pharmaceuticals (TSE:ASP) And Trying To Stomach The 73% Share Price Drop

    Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we...

  • CNW Group

    Acerus Announces Voting Results for the 2019 Annual Meeting

    TORONTO , June 27, 2019 /CNW/ - Acerus Pharmaceuticals Corporation ("Acerus") (ASP.TO) today announced the voting results from its annual meeting of shareholders held on June 27, 2019 in Toronto, Ontario . The six (6) candidates nominated for election to the Acerus board of directors and listed in Acerus' management information circular dated May 15, 2019 , were elected by a majority of the shareholders present in person or represented by proxy at the meeting. Acerus announced today that its shareholders have approved the re‐appointment of PricewaterhouseCoopers LLP as the Auditor of Acerus to hold office until the next annual meeting of shareholders.

  • Associated Press

    Trimel: 3Q Earnings Snapshot

    On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 1 cent. The drugmaker posted revenue of $1.6 million in the period. The company's shares closed at 17 cents. A year ago, ...